Evidence map›Paper›PMID 32582156›Full record

Trial reportFrontiers in immunology2020

Allogenic Adipose Tissue-Derived Stromal/Stem Cells and Vitamin D Supplementation in Patients With Recent-Onset Type 1 Diabetes Mellitus: A 3-Month Follow-Up Pilot Study.

Debora B Araujo, Joana R Dantas, Karina R Silva, Débora L Souto, Maria de Fátima C Pereira, Jessica P Moreira, Ronir R Luiz, Cesar S Claudio-Da-Silva, Monica A L Gabbay, Sergio A Dib and 10 more

Registry-linked trialOpen access · goldAbstract readClinical Trial, Phase II
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05308836 (Phase I Open Label Clinical Trial to Evaluate Safety of Adipose Derived Mesenchymal Stem Cell Transplantation for Type 1 Diabetes Treatment), which is not on this map. Cited by 28 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 3 pooled it
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05308836 phase1completednot on this mapstarted 2021, after this paper: background citation

Phase I Open Label Clinical Trial to Evaluate Safety of Adipose Derived Mesenchymal Stem Cell Transplantation for Type 1 Diabetes Treatment

TypeinterventionalSponsorVinmec Research Institute of Stem Cell and Gene TechnologyRan2021 to 2024Enrolled10ConditionsType 1 DiabetesArmsadipose-derived messenchymal stem cell
3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 3 syntheses or guidelines pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 5 institutions in 1 country.

Debora B AraujoFederal University of Rio de Janeiro, Nutrology and Diabetes Department, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Joana R DantasFederal University of Rio de Janeiro, Nutrology and Diabetes Department, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Karina R SilvaLaboratory of Tissue Bioengineering, National Institute of Metrology, Quality and Technology (Inmetro), Rio de Janeiro, Brazil.
Débora L SoutoNutrology and Diabetes Department, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Maria de Fátima C PereiraClinical Pathology Service, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Jessica P MoreiraBiostatistics Department, Institute of Public Health Studies, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Ronir R LuizBiostatistics Department, Institute of Public Health Studies, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Cesar S Claudio-Da-SilvaPlastic Surgery Department, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Monica A L GabbayDepartment of Stem Cell Therapy, Federal University of São Paulo (UNIFESP), São Paulo, Brazil.
Sergio A DibDepartment of Stem Cell Therapy, Federal University of São Paulo (UNIFESP), São Paulo, Brazil.
Carlos E B CouriUniversity of São Paulo, São Paulo, Brazil.
Angelo MaiolinoHematology Department, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Carmen L K RebelattoCore Cell Technology, Pontifical Catholic University of Paraná, Curitiba, Brazil.
Debora R DagaCore Cell Technology, Pontifical Catholic University of Paraná, Curitiba, Brazil.
Alexandra C SenegagliaCore Cell Technology, Pontifical Catholic University of Paraná, Curitiba, Brazil.
Paulo R S BrofmanSurgical Clinic D at University of Sao Paulo, Core Cell Technology, Pontifical Catholic University of Paraná, Curitiba, Brazil.
Leandra Santos BaptistaLaboratory of Tissue Bioengineering, National Institute of Metrology, Quality and Technology (Inmetro), Rio de Janeiro, Brazil.
José E P OliveiraNutrology and Diabetes Department, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Lenita ZajdenvergNutrology and Diabetes Department, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Melanie RodackiNutrology and Diabetes Department, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Universidade Federal do Rio de Janeiro · BRPontifícia Universidade Católica do Paraná · BRUniversidade de São Paulo · BRUniversidade Federal de São Paulo · BRInstituto Nacional de Metrologia, Qualidade e Tecnologia · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Dietary SupplementsMesenchymal Stem Cell TransplantationAdipose TissueAdolescentAdultBiomarkersBlood GlucoseBrazilCholecalciferolCombined Modality TherapyDiabetes Mellitus, Type 1FemaleGlycated HemoglobinHumansHypoglycemic AgentsInsulinBiomarkersBlood GlucoseCholecalciferolGlycated Hemoglobinhemoglobin A1c protein, humanHypoglycemic AgentsInsulinVitaminsadipose tissue-derived stromal/stem cellspancreatic functiontransplanttype 1 diabetesvitamin D

Identifiers

PMID32582156
PMCPMC7280537
OpenAlexW3033609107

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.